# Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

> **NCT00005850** · PHASE2 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 21 (actual)

## Conditions studied

- Anxiety Disorder
- Depression
- Fatigue
- Lung Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** fluoxetine
- **DRUG:** gemcitabine hydrochloride

## Key facts

- **NCT ID:** NCT00005850
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** 2003-09
- **Final completion:** 2003-09
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2016-07-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005850, "Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00005850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*